Tag: Initial
Warrantee Inc. Announces Pricing of Initial Public Offering – Warrantee (NASDAQ:…...
Tokyo, Japan, July 25, 2023 (GLOBE NEWSWIRE) -- Warrantee Inc. (the "Company" or "Warrantee"), a Japanese marketing and market research technology...
Prestige Wealth Inc. Announces Pricing of Initial Public Offering – Prestige...
Hong Kong, July 06, 2023 (GLOBE NEWSWIRE) -- Prestige Wealth Inc. (the "Company" or "Prestige Wealth"), a wealth management and asset...
VESTA ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING OF US$387.5 MILLION (GROSS...
MEXICO CITY, June 29, 2023 /PRNewswire/ -- Corporación Inmobiliaria Vesta, S.A.B. de C.V. ("Vesta"), a fully-integrated, internally managed real estate company that owns,...
NexImmune Presents Initial Positive Data from the NEXI-001 Phase 1 Trial...
- Trial includes high risk AML patients that have relapsed post allo-HSCT and are refractory to salvage therapy- NEXI-001 is well tolerated with...
Genmab Announces Initial Resolution of Its Second Arbitration Under License Agre…...
Company AnnouncementCOPENHAGEN, Denmark; April 21, 2023 – Genmab A/S (Nasdaq: GMAB) announced today an award in the second arbitration arising under its license...
Lithium Royalty Corp. Files Final Prospectus and Announces Pricing of Initial...
/NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES NEWS WIRE SERVICES/TORONTO, March 8, 2023 /CNW/ - Lithium Royalty Corp. ("LRC",...
Vertex Announces $50 Million Commitment to Health Equity With Three Initial...
– Vertex grant to JDRF supports efforts to improve clinical trial diversity in type 1 diabetes –
– The Vertex Foundation grant supports the...
Prime Number Acquisition I Corp. Announces Pricing of $60 Million Initial...
NEW YORK, May 12, 2022 /PRNewswire/ -- Prime Number Acquisition I Corp. (the "Company"), a newly organized blank check company incorporated as a Delaware...
HilleVax Announces Pricing of Upsized Initial Public Offering – Benzinga –...
BOSTON, April 28, 2022 (GLOBE NEWSWIRE) -- HilleVax, Inc. HLVX, a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines,...
Published Research Shows Initial Results from SARS-CoV-2 Surveillance Studies Su… –...
INNOVATIVE RESPONSE SUPPORTS FUTURE RESPONSES AGAINST SIMILAR PANDEMIC THREATS
First results from the CDC SARS-CoV-2 U.S. variant surveillance program to be published
Positive COVID samples...